Progression of coronary disease in a Behcet's patient in remission

Anil Abeyewickreme1, Anil Ramoutar, Alamgir Kabir

  • 1Department of Medicine, University College London Hospital, London, UK. anila1000@gmail.com

BMJ Case Reports
|July 5, 2012
PubMed

Insights

Behcet's disease can cause heart problems like aneurysms and thrombosis, even when other symptoms improve. Continued immunosuppression may be needed to manage coronary disease progression in these patients.

Area of Science:

  • Cardiovascular Medicine
  • Rheumatology
  • Immunology

Background:

  • Behcet's disease is a systemic vasculitis affecting various organs.
  • Cardiac involvement in Behcet's disease includes accelerated atherosclerosis, aneurysm formation, and thrombosis.
  • Current treatment for Behcet's disease involves immunosuppression, primarily for external manifestations.

Observation:

  • A case of a Behcet's disease patient with aneurysmal coronary artery disease is presented.
  • Coronary disease progression was observed despite remission of external Behcet's disease symptoms.
  • Internal disease manifestations, such as coronary artery disease, can progress silently.

Findings:

  • Coronary artery disease in Behcet's patients can progress even when external symptoms are controlled with immunosuppression.
  • Internal vasculitis may advance in the absence of external symptoms, often coinciding with cessation of immunosuppressive therapy.
  • This case highlights the potential for significant cardiac pathology in Behcet's disease.

Implications:

  • The findings suggest that immunosuppression might need to be continued in Behcet's patients with coronary disease to prevent progression.
  • There is a need to consider specific treatment protocols for Behcet's-related coronary artery disease.
  • Further clinical trials are essential to evaluate the efficacy of immunosuppressive therapy for managing coronary disease in Behcet's patients.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...